Total Payments
$181,569
2024 Payments
$1,431
Companies
49
Transactions
700
Medicare Patients
16,859
Medicare Billing
$1.2M
Payment Breakdown by Category
Other$152,928 (84.2%)
Travel$15,626 (8.6%)
Food & Beverage$12,809 (7.1%)
Education$204.83 (0.1%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $152,928 | 63 | 84.2% |
| Travel and Lodging | $15,626 | 82 | 8.6% |
| Food and Beverage | $12,809 | 550 | 7.1% |
| Education | $204.83 | 5 | 0.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Gilead Sciences, Inc. | $77,660 | 103 | $0 (2019) |
| Amarin Pharma Inc. | $40,968 | 58 | $0 (2021) |
| Novartis Pharmaceuticals Corporation | $28,563 | 54 | $0 (2022) |
| Janssen Pharmaceuticals, Inc | $20,482 | 105 | $0 (2024) |
| Otsuka America Pharmaceutical, Inc. | $7,303 | 13 | $0 (2018) |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | $867.91 | 68 | $0 (2024) |
| Amgen Inc. | $845.27 | 63 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $410.40 | 26 | $0 (2024) |
| SANOFI-AVENTIS U.S. LLC | $402.47 | 20 | $0 (2023) |
| E.R. Squibb & Sons, L.L.C. | $359.36 | 32 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,431 | 73 | Kiniksa Pharmaceuticals International, plc ($150.93) |
| 2023 | $1,137 | 47 | ABIOMED ($184.60) |
| 2022 | $831.20 | 46 | Janssen Pharmaceuticals, Inc ($208.32) |
| 2021 | $1,067 | 62 | AstraZeneca Pharmaceuticals LP ($127.82) |
| 2020 | $7,084 | 44 | Amarin Pharma Inc. ($6,612) |
| 2019 | $35,396 | 111 | Amarin Pharma Inc. ($34,314) |
| 2018 | $21,877 | 83 | Gilead Sciences, Inc. ($12,393) |
| 2017 | $112,745 | 234 | Gilead Sciences Inc ($65,222) |
All Payment Transactions
700 individual payment records from CMS Open Payments — Page 1 of 28
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/16/2024 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | LifeVest (Device) | Food and Beverage | Cash or cash equivalent | $13.63 | General |
| Category: Electromedical and Electrotherapeutic Apparatus | ||||||
| 12/12/2024 | Abbott Laboratories | CARDIOMEMS (Device) | Food and Beverage | In-kind items and services | $23.46 | General |
| Category: Heart Failure | ||||||
| 12/10/2024 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $13.94 | General |
| Category: Cardiology | ||||||
| 12/05/2024 | Esperion Therapeutics, Inc. | NEXLETOL (Drug) | Food and Beverage | In-kind items and services | $16.24 | General |
| Category: ANTILIPEMIC AGENTS | ||||||
| 11/20/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $25.88 | General |
| Category: DIABETES | ||||||
| 11/20/2024 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | LifeVest (Device) | Food and Beverage | Cash or cash equivalent | $9.63 | General |
| Category: Electromedical and Electrotherapeutic Apparatus | ||||||
| 11/19/2024 | Kiniksa Pharmaceuticals International, plc | Arcalyst (Drug) | Food and Beverage | In-kind items and services | $29.29 | General |
| Category: Not Applicable | ||||||
| 11/14/2024 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $20.02 | General |
| Category: Cardiovascular | ||||||
| 11/13/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $20.47 | General |
| Category: Cardio-renal | ||||||
| 11/12/2024 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $15.13 | General |
| Category: Cardiology | ||||||
| 11/06/2024 | SCPHARMACEUTICALS INC. | FUROSCIX (Drug) | Food and Beverage | In-kind items and services | $21.88 | General |
| Category: Cardiology | ||||||
| 11/05/2024 | Philips North America LLC | (CK7) Extended Holter (Device) | Food and Beverage | Cash or cash equivalent | $22.33 | General |
| Category: Medical Device | ||||||
| 10/30/2024 | Esperion Therapeutics, Inc. | NEXLETOL (Drug) | Food and Beverage | In-kind items and services | $20.75 | General |
| Category: ANTILIPEMIC AGENTS | ||||||
| 10/30/2024 | ZOLL Respicardia, Inc. | remede System (Device) | Food and Beverage | Cash or cash equivalent | $18.84 | General |
| Category: Respiratory | ||||||
| 10/29/2024 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | LifeVest (Device) | Food and Beverage | Cash or cash equivalent | $10.81 | General |
| Category: Electromedical and Electrotherapeutic Apparatus | ||||||
| 10/08/2024 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $15.09 | General |
| Category: Cardiology | ||||||
| 10/04/2024 | CVRx, Inc. | Barostim Neo System (Device) | Food and Beverage | Cash or cash equivalent | $17.53 | General |
| Category: Heart Failure and Hypertension | ||||||
| 10/02/2024 | Kiniksa Pharmaceuticals International, plc | Arcalyst (Drug) | Food and Beverage | In-kind items and services | $21.74 | General |
| Category: Not Applicable | ||||||
| 09/26/2024 | E.R. Squibb & Sons, L.L.C. | CAMZYOS (Drug) | Food and Beverage | Cash or cash equivalent | $19.54 | General |
| Category: Cardiovascular | ||||||
| 09/23/2024 | CVRx, Inc. | Barostim Neo System (Device) | Food and Beverage | Cash or cash equivalent | $11.91 | General |
| Category: Heart Failure and Hypertension | ||||||
| 09/19/2024 | ShockWave Medical, Inc | Shockwave IVL System with the Shockwave C2 Coronary IVL Catheter (Device) | Food and Beverage | In-kind items and services | $23.74 | General |
| Category: Lithoplasty | ||||||
| 09/12/2024 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $14.17 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 09/12/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $13.11 | General |
| Category: Obesity | ||||||
| 09/11/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $27.76 | General |
| Category: DIABETES | ||||||
| 08/26/2024 | Esperion Therapeutics, Inc. | NEXLETOL (Drug) | Food and Beverage | In-kind items and services | $20.75 | General |
| Category: ANTILIPEMIC AGENTS | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 34 | 5,166 | 6,241 | $1.3M | $375,096 |
| 2022 | 34 | 4,405 | 5,959 | $1.1M | $315,813 |
| 2021 | 35 | 3,988 | 5,270 | $1.0M | $295,252 |
| 2020 | 34 | 3,300 | 4,462 | $724,466 | $215,575 |
Total Patients
16,859
Total Services
21,932
Medicare Billing
$1.2M
Procedure Codes
152
All Medicare Procedures & Services
152 procedure records from CMS Medicare Utilization — Page 1 of 7
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 901 | 1,542 | $493,400 | $140,602 | 28.5% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Facility | 2023 | 706 | 709 | $124,757 | $34,769 | 27.9% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 215 | 356 | $92,528 | $32,492 | 35.1% |
| 93925 | Ultrasound of leg arteries or artery grafts | Office | 2023 | 106 | 106 | $54,788 | $23,430 | 42.8% |
| 93880 | Ultrasound of both sides of head and neck blood flow | Office | 2023 | 114 | 115 | $50,740 | $19,095 | 37.6% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Office | 2023 | 292 | 297 | $111,836 | $17,399 | 15.6% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 130 | 130 | $54,990 | $14,666 | 26.7% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 108 | 108 | $54,361 | $14,330 | 26.4% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 129 | 133 | $45,668 | $13,258 | 29.0% |
| 78452 | Nuclear medicine studies of heart muscle at rest and with stress and spect | Facility | 2023 | 215 | 215 | $41,925 | $12,411 | 29.6% |
| 93312 | Ultrasound of heart with probe in esophagus, with report | Facility | 2023 | 127 | 128 | $34,816 | $10,430 | 30.0% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 61 | 74 | $13,591 | $4,473 | 32.9% |
| 93016 | Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision by physician | Facility | 2023 | 257 | 258 | $14,190 | $4,112 | 29.0% |
| 92960 | External shock to heart to regulate heart beat | Facility | 2023 | 48 | 49 | $19,159 | $4,025 | 21.0% |
| 93880 | Ultrasound of both sides of head and neck blood flow | Facility | 2023 | 101 | 101 | $10,201 | $2,770 | 27.2% |
| 93018 | Exercise or drug-induced heart stress test with electrocardiogram (ecg) with review by physician | Facility | 2023 | 257 | 258 | $9,546 | $2,750 | 28.8% |
| 93308 | Ultrasound of heart, follow-up | Facility | 2023 | 123 | 132 | $8,328 | $2,496 | 30.0% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 17 | 17 | $7,718 | $2,237 | 29.0% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 211 | 214 | $14,766 | $2,194 | 14.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2023 | 27 | 28 | $8,762 | $2,147 | 24.5% |
| 93793 | Anticoagulant management of patient taking warfarin | Office | 2023 | 103 | 239 | $6,931 | $1,816 | 26.2% |
| 93320 | Ultrasound of heart blood flow, valves and chambers | Facility | 2023 | 124 | 124 | $5,580 | $1,689 | 30.3% |
| 93925 | Ultrasound of leg arteries or artery grafts | Facility | 2023 | 56 | 57 | $5,643 | $1,685 | 29.9% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Facility | 2023 | 16 | 16 | $6,708 | $1,507 | 22.5% |
| 93350 | Ultrasound of heart during rest, exercise and/or drug-induced stress with report | Facility | 2023 | 26 | 26 | $4,550 | $1,302 | 28.6% |
About Dr. Marcus Cox, MD
Dr. Marcus Cox, MD is a Cardiovascular Disease healthcare provider based in Jacksonville Beach, Florida. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/26/2007. The National Provider Identifier (NPI) number assigned to this provider is 1922298868.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Marcus Cox, MD has received a total of $181,569 in payments from pharmaceutical and medical device companies, with $1,431 received in 2024. These payments were reported across 700 transactions from 49 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($152,928).
As a Medicare-enrolled provider, Cox has provided services to 16,859 Medicare beneficiaries, totaling 21,932 services with total Medicare billing of $1.2M. Data is available for 4 years (2020–2023), covering 152 distinct procedure/service records.
Ad
Practice Information
- Specialty Cardiovascular Disease
- Other Specialties Cardiovascular Disease, Cardiovascular Disease
- Location Jacksonville Beach, FL
- Active Since 07/26/2007
- Last Updated 11/13/2025
- Taxonomy Code 207RC0000X
- Entity Type Individual
- NPI Number 1922298868
Products in Payments
- Ranexa (Drug) $77,232
- Vascepa (Drug) $40,968
- ENTRESTO (Drug) $28,499
- XARELTO (Drug) $20,397
- SAMSCA (Drug) $7,303
- LifeVest (Device) $867.91
- Repatha (Biological) $487.21
- ELIQUIS (Drug) $384.49
- Corlanor (Drug) $358.06
- FARXIGA (Drug) $289.75
- Letairis (Drug) $275.00
- MULTAQ (Drug) $267.20
- JARDIANCE (Drug) $233.45
- Arcalyst (Drug) $219.88
- Reveal LINQ (Device) $204.04
- Impella (Device) $184.60
- NEXLETOL (Drug) $178.91
- Barostim Neo System (Device) $169.22
- PRALUENT (Drug) $135.27
- AVYCAZ (Drug) $128.28
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Cardiovascular Disease Doctors in Jacksonville Beach
Dr. Carlos Sotolongo, Md, MD
Cardiovascular Disease — Payments: $9,913
Cardiovascular Disease $9,913
Kristen Currie, M.d, M.D
Cardiovascular Disease — Payments: $7,577
Cardiovascular Disease $7,577
Thomas Hilton, Md, MD
Cardiovascular Disease — Payments: $6,415
Cardiovascular Disease $6,415
William Wainwright, Md, MD
Cardiovascular Disease — Payments: $1,880
Cardiovascular Disease $1,880
Dr. Maedeh Ganji, M.d, M.D
Cardiovascular Disease — Payments: $1,046
Cardiovascular Disease $1,046